SCHEMBL283937

SCHEMBL283937

CCCCCCCCCCCCCCCCCC(=O)NCCCO

nearest known ligand 0.75

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.75
DNM1 Q05193 2/20 0.71
FAAH O00519 4/20 0.70
CASP2 P42575 1/20 0.68
CNR1 P21554 4/20 0.66
SELP P16109 1/20 0.63
ALDH1A1 P00352 2/20 0.61
HPGD P15428 2/20 0.61
TRPV1 Q8NER1 1/20 0.61
MEN1 O00255 1/20 0.61
MAPT P10636 1/20 0.61
ALOX12 P18054 1/20 0.61
BLM P54132 1/20 0.61
KMT2A Q03164 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
EPHX2 P34913 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8623682 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
SCHEMBL1109952 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
N-(3-Hydroxypropyl)Palmitamide SCHEMBL284314 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
SCHEMBL1109946 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
SCHEMBL18265497 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
SCHEMBL7111087 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
SCHEMBL1289305 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
SCHEMBL16390199 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
SCHEMBL281727 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1
SCHEMBL26393721 1.00 NAAA (0.75) NAAADNM1FAAHCASP2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1820034-A Polyolefin adhesive compositions and articles made therefrom EXXONMOBIL CHEMICAL PATENTES I (US) 2006-08-16 CN claimed
US-20240390471-A1 COMPOUNDS AND ADJUVANT FORMULATIONS USEFUL IN PNEUMOCOCCAL VACCINES MERCK SHARP & DOHME LLC (US) 2024-11-28 US disclosed
US-20210347962-A1 COMPOSITIONS COMPRISING ESTOLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME BIOSYNTHETIC TECHNOLOGIES, LLC (US) 2021-11-11 US disclosed
US-20190292350-A1 COMPOSITIONS COMPRISING ESTOLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME BIOSYNTHETIC TECHNOLOGIES LLC (US) 2019-09-26 US disclosed
US-20190284499-A1 LUBRICANT COMPOSITION EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2019-09-19 US disclosed
EP-3536767-A1 LUBRICANT COMPOSITION ExxonMobil Research and Engineering Company (US) 2019-09-11 EP disclosed
EP-2832832-B1 LUBRICATING OIL COMPOSITION JX NIPPON OIL & ENERGY CORP (JP) 2019-06-05 EP disclosed
US-10240025-B2 Compositions comprising estolide compounds and methods of making and using the same BIOSYNTHETIC TECHNOLOGIES, LLC (US) 2019-03-26 US disclosed
US-20180112060-A1 COMPOSITIONS COMPRISING ESTOLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME BIOSYNTHETIC TECHNOLOGIES LLC (US) 2018-04-26 US disclosed
US-9840606-B2 Compositions comprising estolide compounds and methods of making and using the same BIOSYNTHETIC TECHNOLOGIES, LLC (US) 2017-12-12 US disclosed
EP-0614911-B1 Compounds having a sulfonamide and an amidinegroup, process for preparation and pharmaceutical compositions comprising them SANOFI SA (FR) 1999-04-28 EP disclosed
EP-0421441-B1 Pantothenic acid derivatives FUJIREBIO KK (JP) 1995-01-25 EP disclosed
EP-0614911-A1 Compounds having a sulfonamide and an amidinegroup, process for preparation and pharmaceutical compositions comprising them SANOFI (FR) 1994-09-14 EP disclosed
US-5120738-A Cardiovascular disorders FUJIREBIO INC. (JP) 1992-06-09 US disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
US-4900455-A Finishes for stable fibers of synthetic polymers BAYER AKTIENGESELLSCHAFT (DE) 1990-02-13 US disclosed
EP-0009866-B1 PHENOLIC ESTERAMIDE ANTIOXIDANTS AND THEIR USE UNIROYAL, INC. (US) 1982-08-04 EP disclosed
US-4305868-A Phenolic esteramide antioxidants UNIROYAL, INC. (US) 1981-12-15 US disclosed
EP-0009866-A1 Phenolic esteramide antioxidants and their use UNIROYAL, INC. (US) 1980-04-16 EP disclosed
US-4039562-A MALEIC ANHYDRIDE, FATTY ALCOHOL, ALKALI METAL SULFITE REWO CHEMISCHE WERKE G.M.B.H. (DT) 1977-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240390471-A1 COMPOUNDS AND ADJUVANT FORMULATIONS USEFUL IN PNEUMOCOCCAL VACCINES PHOSPHO1, NAPEPLD, PLA2G2E NAAA 159/4885DNM1 2699/4885FAAH 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.